Tudor Investment Corp Portfolio holdings
AUM
$13.2B
1-Year Return
6.99%
This Quarter Return
+0.04%
1 Year Return
+6.99%
3 Year Return
+37.99%
5 Year Return
+86.9%
10 Year Return
+285.99%
AUM
$6.82B
AUM Growth
+$696M
(+11%)
Cap. Flow
+$826M
Cap. Flow
% of AUM
12.1%
Top 10 Holdings %
Top 10 Hldgs %
18.77%
Holding
2,084
New
441
Increased
474
Reduced
467
Closed
480
Top Buys
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$243M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$176M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$168M |
| 4 |
DEN
Denbury Inc.
DEN
|
+$81.9M |
| 5 |
VMW
VMware, Inc
VMW
|
+$78.2M |
Top Sells
| 1 |
LSI
Life Storage, Inc.
LSI
|
+$72.7M |
| 2 |
NVIDIA
NVDA
|
+$71.4M |
| 3 |
Meta Platforms (Facebook)
META
|
+$57.9M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$54.6M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$51.6M |
Sector Composition
| 1 | Technology | 25.79% |
| 2 | Healthcare | 15.07% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Industrials | 11.43% |
| 5 | Financials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Zeta Global
ZETA
$4.88B
| $168K | ﹤0.01% |
20,115
-17,149
| -46% | -$143K |
|
1352
Myriad Genetics
MYGN
$693M
| $166K | ﹤0.01% |
10,356
-34,323
| -77% | -$551K |
|
1353
Recursion Pharmaceuticals
RXRX
$2.13B
| $165K | ﹤0.01% |
+21,544
| New | +$165K |
|
1354
Akebia Therapeutics
AKBA
$787M
| $162K | ﹤0.01% |
142,274
| – | – |
|
1355
JetBlue
JBLU
$1.88B
| $157K | ﹤0.01% |
+34,072
| New | +$157K |
|
|
TVRD
1356
Tvardi Therapeutics, Inc. Common Stock
TVRD
$322M
| $156K | ﹤0.01% |
2,587
-2,718
| -51% | -$164K |
|
|
CANO
1357
DELISTED
Cano Health, Inc.
CANO
| $155K | ﹤0.01% |
6,117
| – | – |
|
1358
1-800-Flowers.com
FLWS
$329M
| $154K | ﹤0.01% |
22,025
-55,239
| -71% | -$387K |
|
|
REFI
1359
Chicago Atlantic Real Estate Finance
REFI
$284M
| $150K | ﹤0.01% |
10,200
| – | – |
|
|
CONN
1360
DELISTED
Conn's Inc.
CONN
| $150K | ﹤0.01% |
37,926
-11,425
| -23% | -$45.1K |
|
1361
Lands' End
LE
$465M
| $147K | ﹤0.01% |
19,714
-4,658
| -19% | -$34.8K |
|
1362
Blend Labs
BLND
$1.13B
| $147K | ﹤0.01% |
107,055
-19,712
| -16% | -$27K |
|
1363
Lemonade
LMND
$3.69B
| $146K | ﹤0.01% |
12,538
+15
| +0.1% | +$174 |
|
1364
SGHC Ltd
SGHC
$6.42B
| $143K | ﹤0.01% |
38,751
| – | – |
|
1365
Bilibili
BILI
$9.94B
| $141K | ﹤0.01% |
+10,259
| New | +$141K |
|
1366
Bausch Health
BHC
$2.67B
| $141K | ﹤0.01% |
+17,175
| New | +$141K |
|
1367
ProKidney
PROK
$379M
| $141K | ﹤0.01% |
+30,727
| New | +$141K |
|
1368
Q32 Bio
QTTB
$22.8M
| $135K | ﹤0.01% |
6,424
| – | – |
|
|
CLDT
1369
Chatham Lodging
CLDT
$352M
| $131K | ﹤0.01% |
13,700
-75,056
| -85% | -$718K |
|
1370
StoneCo
STNE
$4.84B
| $131K | ﹤0.01% |
12,255
-1,284
| -9% | -$13.7K |
|
|
ARI
1371
Apollo Commercial Real Estate
ARI
$1.54B
| $130K | ﹤0.01% |
+12,863
| New | +$130K |
|
1372
Organogenesis Holdings
ORGO
$629M
| $126K | ﹤0.01% |
39,611
-24,721
| -38% | -$78.6K |
|
1373
eHealth
EHTH
$124M
| $123K | ﹤0.01% |
16,614
-4,297
| -21% | -$31.8K |
|
|
IGMS
1374
DELISTED
IGM Biosciences
IGMS
| $121K | ﹤0.01% |
14,486
+3,145
| +28% | +$26.3K |
|
1375
Cato Corp
CATO
$89.4M
| $121K | ﹤0.01% |
15,750
| – | – |
|